精神病性障碍亚组的预后验证与遗传基础探索:PsyCourse研究
该多中心纵向队列研究对1223例精神病性障碍患者用非负矩阵因子分解聚类,在发现样本中识别出5个亚组,各亚组症状轨迹与功能结局不同,教育程度多基因评分有差异而诊断性多基因风险无差异,结果在验证样本中大部分重复。
要点
- 数据驱动方法识别出5个精神病性障碍亚组,各具临床特征与1.5年病程轨迹。
- 抑郁型与严重型亚组功能最低,呈部分恢复后复发的二次方病程。
- 仅教育程度多基因评分有亚组差异,诊断性多基因风险无差异。
核心结论
- 精神病性障碍可数据驱动地分为5个临床签名与病程各异的亚组,且对非诊断性遗传标记有特异性。
研究设计与样本
- 多中心自然主义纵向队列研究,2012年1月起在18个中心收集转诊样本1223例,发现样本765例、验证样本458例,诊断包括精神分裂症、双相障碍、分裂情感性障碍、分裂样障碍和短暂精神病性障碍。
- 使用188个临床变量的非负矩阵因子分解聚类,混合模型比较病程,协方差分析比较多基因评分,监督学习以45个变量在验证样本中重复。
主要发现
- 发现样本765例中341例(44.6%)为女性,平均(SD)年龄42.7(12.9)岁。
- 识别出5个亚组:情感性精神病性障碍(n=252)、自杀性精神病性障碍(n=44)、抑郁性精神病性障碍(n=131)、高功能精神病性障碍(n=252)和严重精神病性障碍(n=86)。
- 精神病性症状(R2=0.41;95%CI,0.38-0.44)、抑郁症状(R2=0.28;95%CI,0.25-0.32)、整体功能(R2=0.16;95%CI,0.14-0.20)和生活质量(R2=0.20;95%CI,0.17-0.23)存在显著的二次方交互项病程。
- 抑郁性和严重精神病性障碍亚组功能最低,呈部分恢复后严重疾病复发的二次方病程。
- 教育程度多基因评分存在亚组差异(平均[SD]偏η2=0.014[0.003]),诊断性多基因风险无差异。
关键数值与推荐
- 使用188个临床变量进行非负矩阵因子分解聚类,以45个最具判别力的变量监督学习重复验证。
- 混合模型比较亚组病程,协方差分析比较多基因评分。
临床怎么用
- 对分层为抑郁性和严重精神病性障碍亚组的患者,需考虑短期至中期服务提供以恢复功能。
- 数据驱动的临床分型方法有助于未来精神病性障碍分类学。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Identifying psychosis subgroups could improve clinical and research precision. Research has focused on symptom subgroups, but there is a need to consider a broader clinical spectrum, disentangle illness trajectories, and investigate genetic associations. OBJECTIVE: To detect psychosis subgroups using data-driven methods and examine their illness courses over 1.5 years and polygenic scores for schizophrenia, bipolar disorder, major depression disorder, and educational achievement. DESIGN, SETTING, AND PARTICIPANTS: This ongoing multisite, naturalistic, longitudinal (6-month intervals) cohort study began in January 2012 across 18 sites. Data from a referred sample of 1223 individuals (765 in the discovery sample and 458 in the validation sample) with DSM-IV diagnoses of schizophrenia, bipolar affective disorder (I/II), schizoaffective disorder, schizophreniform disorder, and brief psychotic disorder were collected from secondary and tertiary care sites. Discovery data were extracted in September 2016 and analyzed from November 2016 to January 2018, and prospective validation data were extracted in October 2018 and analyzed from January to May 2019. MAIN OUTCOMES AND MEASURES: A clinical battery of 188 variables measuring demographic characteristics, clinical history, symptoms, functioning, and cognition was decomposed using nonnegative matrix factorization clustering. Subtype-specific illness courses were compared with mixed models and polygenic scores with analysis of covariance. Supervised learning was used to replicate results in validation data with the most reliably discriminative 45 variables. RESULTS: Of the 765 individuals in the discovery sample, 341 (44.6%) were women, and the mean (SD) age was 42.7 (12.9) years. Five subgroups were found and labeled as affective psychosis (n = 252), suicidal psychosis (n = 44), depressive psychosis (n = 131), high-functioning psychosis (n = 252), and severe psychosis (n = 86). Illness courses with significant quadratic interaction terms were found for psychosis symptoms (R2 = 0.41; 95% CI, 0.38-0.44), depression symptoms (R2 = 0.28; 95% CI, 0.25-0.32), global functioning (R2 = 0.16; 95% CI, 0.14-0.20), and quality of life (R2 = 0.20; 95% CI, 0.17-0.23). The depressive and severe psychosis subgroups exhibited the lowest functioning and quadratic illness courses with partial recovery followed by reoccurrence of severe illness. Differences were found for educational attainment polygenic scores (mean [SD] partial η2 = 0.014 [0.003]) but not for diagnostic polygenic risk. Results were largely replicated in the validation cohort. CONCLUSIONS AND RELEVANCE: Psychosis subgroups were detected with distinctive clinical signatures and illness courses and specificity for a nondiagnostic genetic marker. New data-driven clinical approaches are important for future psychosis taxonomies. The findings suggest a need to consider short-term to medium-term service provision to restore functioning in patients stratified into the depressive and severe psychosis subgroups.
引用
- Dwyer DB, Kalman JL, Budde M, et al. An Investigation of Psychosis Subgroups With Prognostic Validation and Exploration of Genetic Underpinnings: The PsyCourse Study. JAMA Psychiatry. 2020. PMID: 32049274. doi:10.1001/jamapsychiatry.2019.4910
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。